ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
5,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
6,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
7,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
7,3,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
7,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
7,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
7,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,Y
9,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
10,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
11,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
11,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,6,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
12,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
13,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
14,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
14,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
14,3,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
15,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
15,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
15,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
15,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
15,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
15,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
15,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
16,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
16,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
16,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
16,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
16,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
17,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
18,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
18,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
18,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
18,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
19,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
19,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
19,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
19,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
19,6,Headache,Headaches NEC,Headaches,Nerv,N
19,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
20,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
21,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
21,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
21,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
23,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
24,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
25,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
26,1,Scrotal erythema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
27,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
28,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
28,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
29,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,2,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
29,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
29,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Decreased insulin requirement,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
30,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
30,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
31,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
32,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
32,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
32,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
32,4,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
32,5,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
32,6,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
32,7,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
33,1,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
33,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
33,3,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
34,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
35,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
36,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
37,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
38,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
38,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
38,3,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
38,4,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
38,5,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
39,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
39,2,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
40,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
41,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
42,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
43,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
43,3,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,Y
44,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
44,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,3,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
44,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
45,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
45,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
45,3,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
45,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,5,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
45,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
45,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
46,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
47,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
47,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
47,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
47,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
47,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
48,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
49,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
50,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
50,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
50,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
50,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
51,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
52,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
53,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
53,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
55,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
56,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
58,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
58,4,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
58,5,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
58,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
58,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
58,8,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
58,10,Dissociation,Dissociative states,Dissociative disorders,Psych,N
58,11,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
58,12,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
58,13,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
58,14,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
58,15,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
58,16,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
58,17,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
58,18,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,19,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
58,20,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
58,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,22,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,23,Posturing,Stereotypies and automatisms,Changes in physical activity,Psych,N
58,24,Protrusion tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
58,25,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
58,26,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
58,27,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
58,28,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
59,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
59,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
60,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
60,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
61,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
62,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
62,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
63,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
64,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
64,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
64,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
64,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
64,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
65,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
66,1,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
66,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,Y
67,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
68,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
69,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
69,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
69,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
69,5,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
69,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
69,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
69,8,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
69,9,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
69,10,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
69,11,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
69,12,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
70,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
71,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
71,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
72,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
73,1,Central pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
73,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
74,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
74,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
74,3,Metabolic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
76,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
76,2,Metastases to thorax,Metastases to specified sites,Metastases,Neopl,N
76,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
76,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
76,5,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
76,6,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
77,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
78,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
79,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
79,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,2,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
80,3,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
80,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
80,5,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
80,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
80,7,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
80,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
80,9,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
80,10,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
80,11,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,12,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
80,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
80,14,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
80,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,16,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
80,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
80,18,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,19,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
81,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
81,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
81,3,Laryngeal necrosis,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
82,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
83,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
83,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
83,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
83,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
83,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
85,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
86,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
86,3,Refractory cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
87,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
87,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
88,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
88,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
88,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
88,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
89,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
89,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
90,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
91,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
91,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
92,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
92,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
92,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
92,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
92,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
93,1,Tooth resorption,Dental disorders NEC,Dental and gingival conditions,Gastr,N
94,1,Reactive perforating collagenosis,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
95,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
96,1,Collagen disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
96,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,5,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
98,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
98,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
98,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
98,4,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
98,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
98,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,8,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
99,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
99,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
99,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
101,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
101,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
101,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
102,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
102,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
104,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
105,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
105,2,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
106,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
106,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
106,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
106,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
106,5,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
106,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
106,7,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
107,1,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
107,2,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
107,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
107,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
107,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
109,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
109,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
109,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
109,5,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
109,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
111,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
111,2,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
111,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
111,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
112,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
112,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
112,3,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
112,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
113,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
113,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
113,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
114,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
114,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
115,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
115,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
115,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
115,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
115,5,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
115,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
115,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
116,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
116,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
117,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
118,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
120,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
122,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
123,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
124,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
124,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
124,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
124,4,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
125,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
125,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
125,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
125,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
125,5,Respiratory tract haemorrhage,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
126,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
126,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
127,1,Acute cardiac event,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
127,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
127,3,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
127,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
128,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
129,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
129,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
129,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
130,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
131,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
131,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
131,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
131,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
132,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
132,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
132,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
133,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
134,1,Basal ganglia infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
134,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
134,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
134,4,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
134,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
134,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
134,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
134,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
134,9,Pneumonia pseudomonal,Pseudomonal infections,Bacterial infectious disorders,Infec,N
134,10,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
134,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
134,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
135,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
135,2,Blast cell count increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
135,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
135,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
135,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
135,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
136,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
137,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
137,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
137,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
137,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
137,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
138,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
138,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
138,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
138,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
139,1,Acute myeloid leukaemia refractory,Leukaemias acute myeloid,Leukaemias,Neopl,Y
139,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
139,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
140,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
140,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
140,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
140,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
141,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
141,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
141,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
141,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
141,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
141,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
141,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
142,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
142,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
143,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
143,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
143,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
144,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
144,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
144,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
144,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
144,5,Respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
145,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
145,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
145,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
145,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
146,2,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
146,3,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
147,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
147,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
147,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
147,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
148,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
149,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
149,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
150,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
150,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
150,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
150,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
151,1,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
151,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
151,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
152,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
152,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
152,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
152,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
152,5,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
153,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
154,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
154,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
154,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
155,1,Episcleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
155,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
155,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
156,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
156,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
157,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
158,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
158,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
158,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
158,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
158,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
158,6,Sinus arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
159,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
159,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
159,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
159,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
159,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
160,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
160,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
160,3,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
160,4,Hepatoblastoma,Hepatoblastomas,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
160,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
160,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
161,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
161,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
162,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
162,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
162,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
163,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
163,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
164,1,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
165,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
165,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
166,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
166,2,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
166,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
167,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
168,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
168,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
168,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
169,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
169,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
169,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
170,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
170,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
171,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
171,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
172,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
172,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
173,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
173,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
173,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
173,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
173,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
174,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
176,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
177,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
178,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
179,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
179,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
179,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,1,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
180,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
181,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
181,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
181,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
181,4,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
181,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,6,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
182,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
182,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
182,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
182,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
183,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
183,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
183,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
183,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
183,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
183,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
183,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
183,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
184,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
184,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
184,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
185,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
185,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
185,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
186,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
186,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
187,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
187,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
187,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
